Ann: MGC Pharma COVID-19 Business and Operations Update, page-58

I dont know anyone who are lawyers or have done business and corporate law in MBA before, from what I have learnt from my business law unit, its is likely Roby has breached the potential conflicts of interest directors duty by holding directorship in both MGC and KORE aa both companies are in the same industry.

Avoiding conflict of interest is a strict liability of directors and the intention is irrelevant. In other words, just being a director intending to sell KORE is not a defence.

If ASX or ASIC start their investigation in it, I am not entirely sure whether he can get away from it. It all depends when he became the directors of KORE, has he given adequate disclosure and approval from MGC's BOD and depends on the company constitution.